Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus

OBJECTIVE: This study aimed to identify the association between specific short-chain acylcarnitines and cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). METHOD: We retrieved 1,032 consecutive patients with T2DM who meet the inclusion and exclusion criteria from the same tertiary care...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shuo, Liu, Ming-Li, Huang, Bing, Zhao, Fu-Rong, Li, Ying, Cui, Xue-Ting, Lin, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712495/
https://www.ncbi.nlm.nih.gov/pubmed/34970228
http://dx.doi.org/10.3389/fendo.2021.806819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712495/
https://www.ncbi.nlm.nih.gov/pubmed/34970228
http://dx.doi.org/10.3389/fendo.2021.806819

Ejemplares similares